SCHEMBL3160939

SCHEMBL3160939

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ncccn3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ MDM2 Q00987 1/20 0.50
▸ DRD2 P14416 1/20 0.49
▸ DRD4 P21917 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ MAPK1 P28482 2/20 0.48
▸ TSHR P16473 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ ADORA2A P29274 3/20 0.44
▸ ADORA1 P30542 3/20 0.44
▸ THRB P10828 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172350 0.92 THRB (0.55) ALDH1A1KDM4EDRD2DRD4DRD3
SCHEMBL3162425 0.91 EGFR (0.53) ALDH1A1KDM4ETSHRHTTSMN1; SMN2
SCHEMBL3171920 0.89 ADORA1 (0.47) ALDH1A1KDM4EADORA2AADORA1EGFR
SCHEMBL3162096 0.89 OGA (0.45) ALDH1A1KDM4ETDP1DRD4MAPK1
SCHEMBL3172939 0.88 DRD2 (0.44) ALDH1A1KDM4ETDP1DRD2DRD4
SCHEMBL3163144 0.88 ADORA3 (0.46) ALDH1A1KDM4ETSHRSMN1; SMN2POLB
SCHEMBL3164858 0.88 ALDH1A1 (0.49) ALDH1A1KDM4ETSHRSMN1; SMN2ADORA2A
SCHEMBL3163125 0.88 NPC1 (0.47) ALDH1A1KDM4EPOLBADORA2AADORA1
SCHEMBL3164709 0.88 NPC1 (0.47) ALDH1A1KDM4EPOLBADORA2AADORA1
SCHEMBL3175543 0.88 EGFR (0.50) ALDH1A1KDM4ETSHRHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback